Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule and interstitial cell apoptosis in rats

Croatian Medical Journal

Volumn 49, Issue 5, 2008, Pages 600-607

  Radović, Nikola ^a   Čuzić, Snježana ^b   Knotek, Mladen ^c  

^a University of Zagreb School of Medicine   (Croatia)

^b Investigative Laboratory   (Croatia)

^c University of Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CILAZAPRIL; EOSIN; HEMATOXYLIN; LOSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; KIDNEY HOMOGENATE; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MALE; NICK END LABELING; NONHUMAN; RAT; SHAM PROCEDURE; STAINING; TREATMENT OUTCOME; URETER LIGATION; URETER OBSTRUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; CILAZAPRIL; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; KIDNEY TUBULES; LOSARTAN; MALE; RATS; RATS, WISTAR; URETERAL OBSTRUCTION;

EID: 57149108479     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2008.5.600     Document Type: Article

References (34)

1. Truong LD, Petrusevska G, Yang G, Gurpinar T, Shappell S, Lechago J, et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 1996;50:200-7.
2. Thornhill BA, Burt LE, Chen C, Forbes MS, Chevalier RL. Variable chronic partial ureteral obstruction in the neonatal rat: a new model of ureteropelvic junction obstruction. Kidney Int. 2005;67:42-52.
3. Klahr S. Urinary tract obstruction. Semin Nephrol. 2001;21:133-45.
4. Frokiaer J. Pharmacologic intervention in urinary tract obstruction - is it possible? Kidney Int. 2005;68:894-5.
5. Podhorska-Okolow M, Dziegiel P, Gomulkiewicz A, Kisiela D, Dolinska-Krajewska B, Jethon Z, et al. Exercise-induced apoptosis in rat kidney is mediated by both angiotensin II AT1 and AT2 receptors. Histol Histopathol. 2006;21:459-66.
6. Zhang H, Sun GY. Expression and regulation of AT1 receptor in rat lung microvascular endothelial cell. J Surg Res. 2006;134:190-7.
7. Novick AC, Fergany AM. Renovascular hypertension and ischemic nephropathy. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein AJ, editors. Campbell-Walsh urology. 9th ed. Philadelphia (PA): Saunders; 2007. p. 1156-92.
8. Johren O, Dendorfer A, Dominiak P. Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res. 2004;62:460-7.
9. Siragy HM, Bedigian M. Mechanism of action of angiotensin-receptor blocking agents. Curr Hypertens Rep. 1999;1:289-95.
10. Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC, et al. TNF-alpha mediates obstructioninduced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol. 2005;288:F406-11.
11. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16.
12. Alenzi FQ, Warrens AN. Cellular and molecular themes in apoptosis. Wien Klin Wochenschr. 2003;115:563-74.
13. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med. 1999;107:489-506.
14. Zheng TS, Hunot S, Kuida K, Flavell RA. Caspase knockouts: matters of life and death. Cell Death Differ. 1999;6:1043-53.
15. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269-90.
16. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2665-72.
17. Feeney B, Clark AC. Reassembly of active caspase-3 is facilitated by the propeptide. J Biol Chem. 2005;280:39772-85.
18. Truong LD, Choi YJ, Tsao CC, Ayala G, Sheikh-Hamad D, Nassar G, et al. Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases. Kidney Int. 2001;60:924-34.
19. Otsuka F, Yamauchi T, Kataoka H, Mimura Y, Ogura T, Makino H. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats. Am J Physiol. 1998;274:R1797-806.
20. Fujihara CK, Velho M, Malheiros DM, Zatz R. An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int. 2005;67:1913-24.
21. Manucha W, Oliveros L, Carrizo L, Seltzer A, Valles P. Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int. 2004;65:2091-107.
22. Klahr S, Morrissey J. Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage. Kidney Int Suppl. 2002;(82):S23-6.
23. Chevalier RL, Thornhill BA, Wolstenholme JT. Renal cellular response to ureteral obstruction: role of maturation and angiotensin II. Am J Physiol. 1999;277:F41-7.
24. Jones EA, Shahed A, Shoskes DA. Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology. 2000;56:346-51.
25. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol. 2006;290:F4-13.
26. Manucha W. Biochemical-molecular markers in unilateral ureteral obstruction. Biocell. 2007;31:1-12.
27. Kellner D, Chen J, Richardson I, Seshan SV, El Chaar M, Vaughan ED Jr, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol. 2006;176:806-12.
28. Eskild-Jensen A, Paulsen LF, Wogensen L, Olesen P, Pedersen L, Frokiaer J, et al. AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2007;292:F1771-81.
29. Levy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation. 2004;109:8-13.
30. Millatt LJ, Abdel-Rahman EM, Siragy HM. Angiotensin II and nitric oxide: a question of balance. Regul Pept. 1999;81:1-10.
31. Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol. 2002;13:2464-77.
32. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr, Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int. 2001;59:1290-303.
33. Tanji N, Yokoyama M, Terada N, Shudo M, Takeuchi K, Takeuchi M. Renal tubular apoptosis after release of ureteral obstruction in the rat kidney. Int J Urol. 1998;5:256-61.
34. Chen CO, Park MH, Forbes MS, Thornhill BA, Kiley SC, Yoo KH, et al. Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol. 2007;292:F946-55.